Status:
COMPLETED
Exploring the Mechanisms of Indoxyl Sulfate Production by Oral Tryptophan Challenge Test
Lead Sponsor:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Conditions:
Healthy
Chronic Kidney Diseases
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) is prevalent in patients with chronic kidney disease (CKD) and is associated with extremely poor prognosis. Traditional risk factors for the general population, such as di...
Eligibility Criteria
Inclusion
- (1) age older than 20 years
- (2) no exposure to antibiotics or probiotics within the 3 months before entering the study.
Exclusion
- (1) recent gastrointestinal discomfort (such as nausea, vomiting, abdominal pain, constipation, or diarrhea) or
- (2) a history of chronic diseases including diabetes mellites, hypertension, CVD, CKD, liver disease, malignancy, and autoimmune disease.
- (3) pregnancy or breast feeding
- (4) currently use of antipsychotics, Hypnotics, Demerol, Dextromethorphan, tramadol, pentazocine
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2019
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04117191
Start Date
October 1 2019
End Date
November 30 2019
Last Update
December 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Tzu Chi Hospital
New Taipei City, Taiwan, 231